Monoclonal Antibodies in Lymphoma Diagnosis and Classification.

  • S. Poppema
  • H. Hollema
Part of the Developments in Oncology book series (DION, volume 50)

Abstract

The availability of monoclonal antibodies reactive with antigens present on leukocytes and leukocyte subpopulations has enabled a more reliable diagnosis and a more precise subclassification of malignant lymphomas. The wide application of monoclonal antibodies on frozen tissue sections makes one almost forget that the first monoclonal anti T cell reagents were described in 1979 (1), and the first applications of such antibodies on human lymph nodes by immunoperoxidase techniques were in 1981 (2). Since 1973 there had been a significant progress in the histological classification of malignant lymphomas, that was partly based on careful cytological comparisons between the cells of malignant lymphomas and of normal lymphoid tissues, an partly on the results of immunological marker studies, derived from basic imnunology (3, 4). Among these first immunological studies were the demonstration of complement receptors by rosetting techniques on frozen tissue sections of follicular lymphomas in 1974 (5) and the demonstration of cytoplasmic immunoglobulin by immunoperoxidase staining of paraffin tissue sections in 1974 (6).

Keywords

Malignant Lymphoma Hairy Cell Leukemia Hairy Cell Mantle Zone Freeze Tissue Section 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reinherz EL, Kung PC, Goldstein G, Schlossman SF: Separation of functional subsets of human T cells by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 76:4061, 1979.PubMedCrossRefGoogle Scholar
  2. 2.
    Poppema S, Bhan AK, Reinherz EL, McCluskey RT, Schlossman SF: Distribution of T cell subsets in human lymph nodes. J. Exp. Med. 153: 3041, 1981.CrossRefGoogle Scholar
  3. 3.
    Lukes RJ, Collins RD: Immunologic characterization of human malignant lymphomas. Cancer 34: 1488–1503, 1974.PubMedCrossRefGoogle Scholar
  4. 4.
    Gérard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM: Classification of non-Hodgkin’s lymphomas. Lancet 1974; ii, 406.Google Scholar
  5. 5.
    Jaffe ES, Shevach EM, Frank MM: Nodular lymphoma, evidence of origin from follicular B lymphocytes. New Engl. J. Med. 290: 813–819, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    Taylor CR: The nature of Reed-Sternberg cells and other malignant “reticulum” cells. Lancet ii: 802–807, 1974.CrossRefGoogle Scholar
  7. 7.
    Poppema S, Elema JD, Halie MR: The significance of intracytoplasmic proteins in Reed-Sternberg cells. Cancer 42: 1793–1803, 1978.PubMedCrossRefGoogle Scholar
  8. 8.
    Poppema S, Elema JD, Halie MR: The localization of Hodgkin’s disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections. Int. J. Cancer 24: 532–540, 1979.PubMedCrossRefGoogle Scholar
  9. 9.
    Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase procedures. J.Histochem. Cytochem. 29: 577–580, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti alkaline phosphatase. J. Histochem. Cytochem. 32: 219–229, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Warnke RA, Gatter KC, Phil D, Falini B, Hildreth P, Woolston RE, Pulford K, Cordell JL, Cohen B, De WolfPeeters C, Mason DY: Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N. Engl. J. Med. 309: 1275, 1983.PubMedCrossRefGoogle Scholar
  12. 12.
    Epstein AL, Marder RJ, Winter JN, Fox RI: Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalinfixed paraffin embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. J. Immunol. 133: 1028–1036, 1984.PubMedGoogle Scholar
  13. 13.
    Poppema S, Hollema H, Visser L, Vos H: Monoclonal antibodies reactive with lymphocyte subsets in paraffin embedded tissue sections. 1986, Submitted.Google Scholar
  14. 14.
    Hsu SM, Jaffe ES: Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin’s disease. Am. J. Clin. Pathol. 82: 29–32, 1984.PubMedGoogle Scholar
  15. 15.
    Stein H, Uchanska-Ziegler B, Gerdes J, Ziegler A, Wernet P: Hodgkin- and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int. J. Cancer 29: 283–290, 1982.PubMedCrossRefGoogle Scholar
  16. 16.
    Korsmeyer SJ, Greene WC, Cossman J, Hsu SM, Jensen JP, Neckers LM, Marshall SL, Bakshi A, Depper JM, Leonard WJ Jaffe ES, Waldmann TA: Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc, Natl. Acad. USA 80: 4522–4530, 1983.CrossRefGoogle Scholar
  17. 17.
    Schwarting R, Stein H. Wang CY: Monoclonal antibodies S-HCL1 and S-HCL3 allow the diagnosis of hairy cell leukemia. Blood 65: 974–983, 1985.PubMedGoogle Scholar
  18. 18.
    Poppema S, Visser L: Monoclonal antibody reactive with hairy cell leukemia and a minor normal lymphocyte subpopulation. Lab. Invest. 54: 50A, 1986.Google Scholar
  19. 19.
    The non-Hodgkin’s lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas. Cancer 49: 2112–2135, 1982.Google Scholar
  20. 20.
    Molenaar WM, van den Berg HM, Halie MR, Poppema S: The heterogeneity of follicular center cell lymphomas. I Cytohistologic, immunlogic, and enzymehistochemical aspects. Cancer 52: 2269–2276, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Dordrecht 1987

Authors and Affiliations

  • S. Poppema
  • H. Hollema

There are no affiliations available

Personalised recommendations